MHRA: Detailed Description of the Pharmacovigilance System for Parallel Imported Products

There are a small number of instances where a parallel importing company is required to take on responsibility for pharmacovigilance. Examples of such instances include: when the UK reference product licence has been cancelled, when there is no ‘common origin’ between the UK and imported products (standard and complex parallel import applications).